PRAX vs USB · rev $8.6M vs P/E 12, rev $28.66B
Praxis Precision Medicines Inc (PRAX) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
PRAX currently screens at market cap $7.38B. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the PRAX and USB stock pages for the full models.
Not investment advice.